Zurueck zur Suche

Reporte zur Charge U025205

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

19Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
UT 4 NJ 2 CO 2 NY 2 AZ 2 WA 2 IN 1 NC 1 ID 1 CA 1 MA 1

VAERS 2589277

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
IN
Alter
1,0
Geschlecht
M
Eingang
01.03.2023
Impfdatum
20.02.2023
Beginn
21.02.2023
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Injection site erythema Injection site induration Injection site mass Injection site warmth

Symptomtext

Right leg where the shots were given is red, warm to touch, has hard lump. Using Tylenol, Ibuprofen, and icing. improvement after 1 week, but still has lump and slightly red.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2508416

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
UT
Alter
20,0
Geschlecht
F
Eingang
18.11.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contraindicated product administered Exposure during pregnancy Nausea Vomiting

Symptomtext

nausea; vomiting; Dose of VARIVAX was accidently given to a pregnant woman at 11 weeks gestation. She was taking unspecified prenatal vitamins prior to administration and was prescribed the following the day of her appointment: ASPIRIN 81 MG, GINGER 500 MG, ONDANSETRO; VARIVAX was accidently given to a pregnant woman; This spontaneous prospective pregnancy report was received from a nurse practitioner, regarding a 20-years-old female patient. The patient's pertinent medical history included tachycardia as current condition. The patient's previous drug reactions or allergies were not reported. Concomitant medication included prenatal vitamins (not specified). On 17-OCT-2022, at 11 weeks of gestation(last menstrual period was not reported, approximately on 01-AUG-2022), the patient was accidentally vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, 0.5 milliliters subcutaneously as prophylaxis (lot number: U025205, which was determined to be valid, with an expiration date on 13-AUG-2023) (scheme and anatomical location of administration was not reported) (exposure during pregnancy) (Contraindicated product administered). On an unspecified date, the patient was also vaccinated with a flue vaccine (not specified, manufacturer unknown) and a Covid-19 vaccine (not specified, manufacturer unknown) (strengths, doses, schemes, routes and anatomical locations of administration, lot numbers and expiration dates were not reported). On 17-OCT-2022 (reported as after vaccination), the patient experienced nausea and vomiting. The outcome of the events was not reported. The pregnancy outcome was not reported at the time of the report therefore, the fetal outcome was unknown. No additional adverse event was reported. The patient was prescribed on the day of her appointment acetylsalicylic acid (ASPIRIN), ginger, ondansetron, pyridoxine and doxylamine, but by the time of the report it was unclear if she started these medications. The causal relationship between nausea and vomiting and varicella virus vaccine live (Oka/Merck) (VARIVAX) was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Tachycardia
Vorgeschichte
-
Andere Medikamente
PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]
Allergien
-
Vorherige Impfungen
-

VAERS 2508416

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
UT
Alter
20,0
Geschlecht
F
Eingang
18.11.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contraindicated product administered Exposure during pregnancy Nausea Vomiting

Symptomtext

nausea; vomiting; Dose of VARIVAX was accidently given to a pregnant woman at 11 weeks gestation. She was taking unspecified prenatal vitamins prior to administration and was prescribed the following the day of her appointment: ASPIRIN 81 MG, GINGER 500 MG, ONDANSETRO; VARIVAX was accidently given to a pregnant woman; This spontaneous prospective pregnancy report was received from a nurse practitioner, regarding a 20-years-old female patient. The patient's pertinent medical history included tachycardia as current condition. The patient's previous drug reactions or allergies were not reported. Concomitant medication included prenatal vitamins (not specified). On 17-OCT-2022, at 11 weeks of gestation(last menstrual period was not reported, approximately on 01-AUG-2022), the patient was accidentally vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, 0.5 milliliters subcutaneously as prophylaxis (lot number: U025205, which was determined to be valid, with an expiration date on 13-AUG-2023) (scheme and anatomical location of administration was not reported) (exposure during pregnancy) (Contraindicated product administered). On an unspecified date, the patient was also vaccinated with a flue vaccine (not specified, manufacturer unknown) and a Covid-19 vaccine (not specified, manufacturer unknown) (strengths, doses, schemes, routes and anatomical locations of administration, lot numbers and expiration dates were not reported). On 17-OCT-2022 (reported as after vaccination), the patient experienced nausea and vomiting. The outcome of the events was not reported. The pregnancy outcome was not reported at the time of the report therefore, the fetal outcome was unknown. No additional adverse event was reported. The patient was prescribed on the day of her appointment acetylsalicylic acid (ASPIRIN), ginger, ondansetron, pyridoxine and doxylamine, but by the time of the report it was unclear if she started these medications. The causal relationship between nausea and vomiting and varicella virus vaccine live (Oka/Merck) (VARIVAX) was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Nausea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Tachycardia
Vorgeschichte
-
Andere Medikamente
PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]
Allergien
-
Vorherige Impfungen
-

VAERS 2480297

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
NC
Alter
28,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
11.10.2022
Beginn
12.10.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Erythema Injection site erythema Injection site nodule Injection site swelling Peripheral swelling

Symptomtext

Pt received varicella vaccination subQ in the back of her right arm; the next morning, the injection site was red and swollen, with a small knot. Pt states it continued to get worse throughout the day and extended around entire arm. Pt also became dizzy and lightheaded.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
Pt went to primary care doctor on 10/14/2022-- was treated with antibiotics and steriods.
Aktuelle Erkrankungen
None
Vorgeschichte
ADHD
Andere Medikamente
Adderall for ADHD
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2307846

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
NJ
Alter
-
Geschlecht
F
Eingang
03.06.2022
Impfdatum
24.01.2022
Beginn
01.02.2022
Tage bis Beginn
8,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Pruritus

Symptomtext

she started to have unspecififed itching; localised erythema; This spontaneous report has been received from a pharmacist, who was also the patient, a female patient of unknown age referring to herself. The patient's concurrent conditions, medical history, concomitant medications, previous drug reactions, or allergies were reported as none. On 24-JAN-2022, the patient received the first dose of varicella virus vaccine live (oka/merck) (VARIVAX) on an unspecified arm, and on 21-FEB-2022, the patient received the second dose of varicella virus vaccine live (oka/merck) (VARIVAX) in her left arm; both vaccines with route of administration reported as injection, also the same lot number U025205 that has been verified to be a valid lot number with expiry date on 13-AUG-2023, indicated for varicella (strength, dose, and frequency were not provided). On an unspecified date in February 2022 (also reported as a couple of days after the second dose), the patient started to have an unspecified itching that comes and goes predominantly on her arms, but can also be anywhere on her body (pruritus). The patient did not report a rash but did state that after she started itching and began to scratch, the are she scracted became red. Additionally, the patient reached out for medical attention with her health care professional (HCP) and was prescribed prednisone which she started on an unknown date in May 2022 (also reported as earlier this week).. Furthermore, on an unknown date, unspecified lab work was performed and came out with normal results. The outcome of pruritus and erythema was reported as not recovered. The causal relationship between varicella virus vaccine live (oka/merck) (VARIVAX) with pruritus and erythema was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2264587

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
CO
Alter
1,0
Geschlecht
F
Eingang
05.05.2022
Impfdatum
22.04.2022
Beginn
02.05.2022
Tage bis Beginn
10,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Patient received her first MMR and Varicella vaccine on 4/22/22. On May 4th we received a call that the patient had broken out in a widespread, non itchy rash on May 2nd 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2228454

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
NY
Alter
14,0
Geschlecht
M
Eingang
12.04.2022
Impfdatum
26.02.2022
Beginn
14.03.2022
Tage bis Beginn
16,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Erythema Erythema of eyelid Hypersensitivity Inflammation Rash Swelling Swelling of eyelid

Symptomtext

On March 14, 2022, which was day 16 days after receiving the vaccine my son woke up with an extreme allergic reaction. He had pox-like eruptions on his chest, back, forearms and calves. His eyelids and under-eye area were swollen and red. He had red swellings on his neck. He was taken to the same office where he had received the vaccine. They prescribed him a five day pack of prednisone to counter the allergic inflammation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None were done
Aktuelle Erkrankungen
Tinea Cruris
Vorgeschichte
Eczema
Andere Medikamente
Nystatin, Vitamin D, Vitamin C, Probiotic
Allergien
Scallops
Vorherige Impfungen
-

VAERS 2213962

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

mild
Staat
UT
Alter
1,0
Geschlecht
M
Eingang
04.04.2022
Impfdatum
29.03.2022
Beginn
02.04.2022
Tage bis Beginn
4,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Diarrhoea Pyrexia Rash Vomiting

Symptomtext

fever, rash, vomiting, diarrhea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2684983

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
CO
Alter
-
Geschlecht
U
Eingang
22.09.2023
Impfdatum
22.08.2023
Beginn
22.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

patient has not had any symptoms. No additional AE; an expired dose of VARIVAX was administered to a patient; This spontaneous report has been received from a medical assistance referring to a patient of unknown age and gender. Information about concurrent conditions, concomitant medications and medical history was unknown. On 22-AUG-2023, the patient was vaccinated with an expired dose of varicella virus vaccine live (oka/merck)(VARIVAX) (one dosage form, lot # U025205, expiration date: 13-AUG-2023; strength, route and anatomical location were not provided) for prophylaxis (expired product administered). As reported, the vaccine did not have any temperature excursions. The reporter stated that patient did not have any symptoms. No additional adverse event reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2676006

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
AZ
Alter
14,0
Geschlecht
M
Eingang
23.08.2023
Impfdatum
23.08.2023
Beginn
23.08.2023
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Inadvertently administered Varicella vaccine that was due on 09/12/2023. Noticed vial was expired (08/13/2023). Pt tolerated injection and there were no s/sx of adverse reaction status post administration of vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
No known illnesses.
Vorgeschichte
No known chronic or long-standing health conditions.
Andere Medikamente
No known history.
Allergien
No known allergies.
Vorherige Impfungen
-

VAERS 2624412

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
AZ
Alter
1,0
Geschlecht
M
Eingang
01.05.2023
Impfdatum
20.09.2022
Beginn
20.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product preparation error

Symptomtext

PATIENT CAME IN FOR VACCINES 09/20/2022, RN ONLY ADMINISTERED DILUENT. HIB COMPONENT WAS NOT MIXED IN. PATIENTS MOTHER WAS INFORMED AND CORRECT VACCINATION WAS ADMINISTERED 04/04/2023.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation error
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NONE
Vorherige Impfungen
-

VAERS 2485992

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
ID
Alter
-
Geschlecht
U
Eingang
22.10.2022
Impfdatum
-
Beginn
14.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

administration of improperly stored VARIVAX; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On an unknown date, doses of varicella virus vaccine live (oka/merck) (VARIVAX) underwent a temperature excursion of 12 farenheit degrees for 15 minutes. No previous temperature excursion were reported. On 14-OCT-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) lot #U025205, expiration date: 13-AUG-2023 (strength, dosage regimen, anatomical location and route of administration were not provided) as prophylaxis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2452894

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.09.2022
Impfdatum
07.08.2022
Beginn
07.08.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental overdose No adverse event Product storage error

Symptomtext

no addtional AE; inadvertently administered improperly stored vaccine; inadvertentlyadministered for 2 doses to the same patient; This spontaneous report was received from a registered nurse, referring to a patient of unknown age and gender. The patient's medical history, concurrent condition, drug allergies/reactions were not provided. Concomitant therapy included sterile diluent. Two doses of improperly stored varicella virus vaccine live (oka/merck) (VARIVAX) (lot # U025205, expiration date 13-AUG-2023; strength, dose and route were unknown) may have been administered to the patient inadvertently(product storage error, accidental overdose) on 07-AUG-2022 (also reported as on 07-AUG-2022 and "two months later"). Temperature excursion of this vaccine was minus 80 Fahrenheit degrees for 264 hours. There was no previous temperature excursion. No additional adverse event or product quality compliant was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental overdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2430047

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
WA
Alter
1,1
Geschlecht
F
Eingang
06.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Patient was given both a MMRV and a VAR. Patients mother was informed by PCP to give the patient tylenol.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2394507

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
28.07.2022
Impfdatum
08.07.2022
Beginn
08.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product storage error

Symptomtext

No additional AE reported.; VARIVAX was administered to a patient after a prior temperature excursion occured, but before the most recent temperature excursion.; This spontaneous report has been received from a nurse and refers to patient of unknown age and gender. The patient's pertinent medical history, current conditions, previous drug reactions or allergies and concomitant medications were not provided. On 08-JUL-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) subcutaneous injection, at dose 0.5 ml, lot number U025205 has been verified to be valid, expiration date 13-AUG-2023 for prophylaxis (strength, route of administration and anatomical location of vaccination were not provided) that underwent a temperature excursion of 9.4 Fahrenheit degrees (reported as the highest temperature) for 48 hours (product storage error). No additional adverse events were reported. There was a previous temperature excursion of 32.2 Fahrenheit degrees for 5 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2323701

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
NJ
Alter
-
Geschlecht
U
Eingang
18.06.2022
Impfdatum
-
Beginn
01.06.2022
Tage bis Beginn
-
Dosis
1
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No additional adverse events; Nurse administered a dose of VARIVAX that had experienced temperature excursion; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant therapies were not provided On 01-JUN-2022, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) valid lot # U025205, expiration date 13-AUG-2023 for prophylaxis (strength, and route of administration were not provided). The vaccine underwent a temperature excursion (Product storage error). No additional details were available. The patient did not experience any adverse event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2320794

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
UT
Alter
19,0
Geschlecht
M
Eingang
15.06.2022
Impfdatum
15.06.2022
Beginn
15.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Fall Feeling hot Head injury Pallor

Symptomtext

When client was checking out at front desk, he fell backwards and hit his head. Client was pale and feeling hot. Client moved to sitting in chair and was given snacks and beverages to eat while resting. Clients head was checked for any signs of injury. No signs noted. Within 5-10 minutes of resting, clients color was back and he stated he was feeling better. Client rested for an additional 10-15 minutes before leaving the clinic in good condition. Facility incident report filled.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fall
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2307077

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
WA
Alter
1,0
Geschlecht
M
Eingang
02.06.2022
Impfdatum
24.05.2022
Beginn
24.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

12 month old patient given proquad with varicella in single presentation. No symptoms or adverse outcomes.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
none
Allergien
NKA
Vorherige Impfungen
-

VAERS 2169729

MERCK & CO. INC. · VARICELLA (VARIVAX) · Charge U025205

gering
Staat
MA
Alter
-
Geschlecht
U
Eingang
10.03.2022
Impfdatum
03.03.2022
Beginn
03.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

No additional AE; a patient was administered VARIVAX by intramuscular route; This spontaneous report was received from registered nurse referring to a patient of unknown age and gender. The patient's concurrent conditions, medical history and drug reactions/allergies were not reported. On 03-MAR-2022, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) 0.5 mL by intramuscular route (lot #U025205, expiration date 13-AUG-2023; anatomical location not reported) for prophylaxis (incorrect route of product administration). The administered vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) 0.5 mL (lot# and expiration date were not provided). No additional adverse event (AE).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
MERCK STERILE DILUENT
Allergien
-
Vorherige Impfungen
-